Skip to Content

The Best Datreal Yet: Real Estate Maps, a New Design, Dark Mode. Read the Changelog

Datreal

LabKnow AB - Company Valuation

Reference Value. Equity as reported in the selected filing.

Reported Book Equity

640,035 kr
Reference Value
Based on FY
2025
Valuation Date
Business Strength
D+
Altman Z″
3.04
Risks
Loss-Making

Scope & Evidence

Company
LabKnow AB
Registration
SE · 5590794607
Covers
Not stated in the filing
Filings Used
8 · FY 2025, 2024, 2023, 2022, 2021, 2020, 2019, 2018

Key Ratios

Current Ratio
1.70×
Quick Ratio
-
Debt / Equity
2.30×
Equity Ratio
30.3%
Interest Coverage
-
Gross Margin
-
Net Profit Margin
-84.2%
Return on Equity
-10.9%
Return on Assets
-3.3%
Revenue CAGR
-22.9%

Asset Distribution

Fixed AssetsCashReceivablesOther Assets

Liability Maturity

Short-TermLong-Term

3-Year Revenue Scenarios

100k kr
75k kr
50k kr
25k kr
0 kr
202620272028
OptimisticBaseConservative

Revenue vs Industry Peers

Lideta Mälardalen AB
410,101,009 kr
Doktor 24 Healthcare AB
318,065,000 kr
MDHeart Consulting AB
3,448,927 kr
RA Läkarna AB
1,893,580 kr
LabKnow AB ★
82,982 kr

Revenue, Profit & EBITDA

1.1m kr
700k kr
350k kr
0 kr
-350k kr
20212022202320242025
RevenueEBITDANet Profit

Versus Industry Median

600k kr
400k kr
200k kr
0 kr
-200k kr
RevenueNet Profit
This CompanyIndustry Median